![David Kao](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
David Kao is Vice President-Regulatory Affairs at Inhibrx Biosciences, Inc. since 2021.
Former positions include Vice President-Regulatory Affairs at Sanofi AATD, Inc. from 2021 to 2024 and Head-Development Program at Bristol Myers Squibb Co. Education includes undergraduate studies at Rutgers State University of New Jersey, a doctorate from Shenandoah University, and an MBA from Rutgers Business School.
Postes actifs de David Kao
| Sociétés | Poste | Début |
|---|
Anciens postes connus de David Kao
| Sociétés | Poste | Fin |
|---|---|---|
| INHIBRX, INC. | Conseiller Juridique Général | 30/05/2024 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Formation de David Kao
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shenandoah University
 Shenandoah University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rutgers Business School
 Rutgers Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inhibrx, Inc.
 Inhibrx, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops biologic therapeutics for the treatment of cancer | Health Technology |
